Literature DB >> 11229838

Risk factors for severe pulmonary and disseminated coccidioidomycosis: Kern County, California, 1995-1996.

N E Rosenstein1, K W Emery, S B Werner, A Kao, R Johnson, D Rogers, D Vugia, A Reingold, R Talbot, B D Plikaytis, B A Perkins, R A Hajjeh.   

Abstract

Surveillance for coccidioidomycosis (CM) and a case-control study for risk factors among adults were conducted in Kern County, California. From January 1995 through December 1996, 905 cases of CM were identified, for an annual incidence of 86 cases per 100,000 population. A total of 380 adults were enrolled in the case-control study: 77 had severe pulmonary disease, 33 had disseminated disease, and 270 control patients had mild disease. Independent risk factors for severe pulmonary disease included diabetes, recent history of cigarette smoking, income of < $15,000 per year, and older age. Oral antifungal therapy before hospitalization was associated with a reduced risk of CM pneumonia. Risk factors for disseminated disease were black race, income of < $15,000 per year, and pregnancy. Early treatment of CM with oral antifungal agents may prevent severe pulmonary disease in groups considered to be at high risk, such as elderly individuals, persons with diabetes, and smokers. Persons at risk for severe CM may benefit from vaccination once an effective CM vaccine is available.

Entities:  

Mesh:

Year:  2001        PMID: 11229838     DOI: 10.1086/319203

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  52 in total

1.  An archived lot of coccidioidin induces specific coccidioidal delayed-type hypersensitivity and correlates with in vitro assays of coccidioidal cellular immune response.

Authors:  Neil M Ampel; Richard F Hector; Christina P Lindan; George W Rutherford
Journal:  Mycopathologia       Date:  2006-02       Impact factor: 2.574

2.  Clinical usefulness of ELISPOT assay on pericardial fluid in a case of suspected tuberculous pericarditis.

Authors:  A Biglino; P Crivelli; E Concialdi; C Bolla; G Montrucchio
Journal:  Infection       Date:  2008-10-14       Impact factor: 3.553

Review 3.  Cavitary pulmonary disease.

Authors:  L Beth Gadkowski; Jason E Stout
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

4.  Coccidioidomycosis: Experience From a Children's Hospital in an Area of Endemicity.

Authors:  Dimana Dimitrova; Lawrence Ross
Journal:  J Pediatric Infect Dis Soc       Date:  2014-09-15       Impact factor: 3.164

5.  So, if I travel to "Venezuela", can I get coccidioidomycosis?

Authors:  A J Rodriguez-Morales; C E Jiménez-Canizales; A Mondragón-Cardona; A Taype-Rondán; J A Vargas-Gandica
Journal:  Infection       Date:  2014-10-02       Impact factor: 3.553

6.  Disseminated Histoplasmosis with Skin Lesions and Osteomyelitis in a Patient from the Philippines.

Authors:  Marwan M Azar; Maricar F Malinis
Journal:  Am J Trop Med Hyg       Date:  2016-03-14       Impact factor: 2.345

Review 7.  Coccidioidomycosis: host response and vaccine development.

Authors:  Rebecca A Cox; D Mitchell Magee
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

8.  Pyo-mediastinitis: A complication of pulmonary coccidioidomycosis.

Authors:  Mohamed Y Rady; Arturo Lopez; Bhavesh M Patel; Joel S Larson
Journal:  Can J Infect Dis       Date:  2003-05

9.  Coccidioidomycosis-Associated Deaths in California, 2000-2013.

Authors:  Gail L Sondermeyer; Lauren A Lee; Debra Gilliss; Duc J Vugia
Journal:  Public Health Rep       Date:  2016 Jul-Aug       Impact factor: 2.792

10.  Estimating severe coccidioidomycosis in California.

Authors:  Valerie J Flaherman; Richard Hector; George W Rutherford
Journal:  Emerg Infect Dis       Date:  2007-07       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.